the purpose of this study is to develop a score to predict the risk of stroke/ death after CAS.
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Risk of Insulin-Dependent Diabetes Mellitus in Patients Undergoing Carotid Endarterectomy
Objectives: There is conflicting evidence regarding the association of diabetes mellitus (DM) and insulin use on outcomes after carotid endarterectomy (CEA). Therefore, we sought to evaluate the risk of insulindependent DM (IDDM) and non-insulin-dependent DM (NIDDM) on 30-day outcomes after CEA.
Methods: We identified patients undergoing CEA from the TargetedVascular National Surgical Quality Improvement Program (2011 Program ( -2015 and stratified patients based on their preprocedural symptom status. We compared 30-day outcomes between nondiabetics and patients with NIDDM or IDDM, with 30-day stroke/death as a primary end point.
Results: Of 16,739 CEA patients, 9784 (58%) were asymptomatic, of whom 6720 (69%) had no diagnosis of DM, 1109 (11%) had IDDM, and 1955 (20%) had NIDDM. Of the 6955 symptomatic patients, 4982 (72%) had no diagnosis of DM, 810 (12%) had IDDM, and 1163 (17%) had NIDDM. Among asymptomatic patients, patients with IDDM experienced higher rates of 30-day stroke/death compared with those without DM (3.4% vs 1.5%; P < .001), whereas those with NIDDM experienced similar rates as those without DM (2.1% vs 1.5%; P ¼ .1). After adjustment, IDDM was associated with 30-day stroke/death in asymptomatic patients compared with patients without DM (odds ratio, 2.3; 95% confidence interval, 1.5-3.4; P < .001; Table) , but NIDDM was not (odds ratio, 1.4; 95% confidence interval, 1.0-2.1; P ¼ .1). In comparison, among symptomatic patients, those with IDDM and NIDDM experienced similar rates of 30-day stroke/death as patients without DM, with 4.9% versus 3.6% and 4.0% versus 3.6% (both P > .1). After adjustment, neither IDDM nor NIDDM Author Disclosures: T. Bower: Nothing to disclose; R. DeMartino: Nothing to disclose; M. Kalra: Nothing to disclose; P. Rowse: Nothing to disclose.
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The Incidence of Carotid In-Stent Stenosis Is Underestimated: Is It 50% or 80% and Its Clinical Implications Ali F. AbuRahma, Zachary T. AbuRahma, Elliot Adams, Luis Mata, Grant Scott, Matthew Beasley, Scott Dean, Elaine Davis. West Virginia University, Charleston, WV Objectives: The incidence of carotid in-stent stenosis has been reported to vary between 1% and 30%. Most published studies have relatively short follow-up periods, which may lead to underestimating the incidence of carotid in-stent stenosis rates. This study analyzed the incidence of 50% and 80% carotid in-stent restenosis using validated duplex velocity criteria and its clinical implications.
Methods: This retrospective analysis included prospectively collected data from 450 carotid artery stent (CAS) procedures. All patients had postoperative carotid duplex ultrasound examination, which was repeated at 1 month, 6 months, and every 6 to 12 months thereafter. A Kaplan-Meier analysis was used to estimate the freedom rates from 50% in-stent restenosis (internal carotid artery peak systolic velocity of 224 cm/s) and 80% in-stent restenosis (internal carotid artery peak systolic velocity of 325 cm/s) and its clinical implications.
Results: The mean age was 68.3 years, with a mean follow-up of 40.3 months. A total of 201 of 450 patients (45%) underwent CAS for symptomatic disease. Primary CAS was done in 291 patients (65%) and the remaining 35% were done for post-CEA stenosis. A total of 101 patients (23%) had 50% late carotid in-stent restenosis, and of these, 33 (7.4%) had 80% in-stent restenosis. Nineteen patients (4.3%) developed late transient ischemic attack and three (0.7%) late stroke. Twenty-three (5.2%) patients had late reintervention. Rates of freedom from 50% instent restenosis in the whole series were 85%, 79%, 75%, 72%, and 70% at 1, 2, 3, 4, and 5 years, respectively (Fig 1) . The rates of freedom from 50% in-stent restenosis for primary CAS and CAS for post-CEA restenosis were not statistically significant (P ¼ .540). The rates of freedom from 80% in-stent restenosis for the whole series were 96%, 95%, 93%, 90%, and 89% at 1, 2, 3, 4, and 5 years, respectively (Fig 2) . The rates of freedom from 80% in-stent restenosis for primary CAS and CAS for post-CEA restenosis, were also not significant (P ¼ .516). The rates of freedom from reintervention were 98%, 96%, 93%, 93%, and 91% at 1, 2, 3, 4, and 5 years, 
